New pill to prevent flu after exposure
Part of Infections, Lungs & breathing clinical trials.
This study tests a new antiviral pill, GP681, to prevent the flu in people who live with someone who has the flu. If you haven't gotten sick yet and are otherwise healthy, this might help keep you from catching it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live with someone who has the flu, and they were diagnosed in the last 48 hours with a fever.
- You currently have no flu symptoms and test negative for the flu.
- You are 12 years or older.
- You have not received a flu vaccine in the last 6 months.
- You do not have serious health conditions or take medications that affect your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called TRX-100 to see if it can help fight the flu. Healthy volunteers will be exposed to the influenza A virus in a controlled setting to see how the medicine works.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This trial studies whether Apomivir works and is safe for people who likely have the flu and test positive for influenza A or B. You may help researchers learn if treating early can reduce flu illness and side effects.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
This trial tests two flu medicines—Tamiflu and Xofluza—to see if they can prevent flu in people who are staying in a hospital room with a patient who has the flu. You may join if you are a hospitalized close contact (roommate or caregiver) and test negative for flu.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.